Etavopivat

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

Sickle Cell DiseaseLiver DiseaseMyelodysplastic Syndromes

272 competitors in Sickle Cell Disease

#DrugCompanyPhaseTrials

1

Adakveo

Novartis

Phase 3

72

Brilinta

AstraZeneca

Phase 3

33

Campath

GGenzyme, a Sanofi Company

Phase 3

124

Ritalin

Novartis

Phase 3

25

Cysteine Hydrochloride

Novartis

Phase 3

26

Eliquis

Bristol-Myers Squibb

Phase 3

17

Oxbryta

GGlobal Blood Therapeutics

Phase 3

58

Aqvesme

AAgios Pharmaceuticals, Inc.

Phase 3

49

Effient

CCosette Pharmaceuticals, Inc.

Phase 3

310

Xarelto

WWim Janssens

Phase 3

2Show 29 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Sickle Cell Disease7 trials

A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia

Recruiting·Novo Nordisk·Phase 3·NCT06609226·480 enrolled

A Phase 2 Open-label Study to Evaluate the Activity of Etavopivat on Transcranial Doppler Velocities in Pediatric Patients With Sickle Cell Disease Who Are at Increased Risk for Primary Stroke

Recruiting·FForma Therapeutics, Inc.·Phase 2·NCT05953584·27 enrolled

Study of the Effect of Etavopivat on Cerebral Hemodynamic Response in Children With Sickle Cell Disease

Active, not recruiting·Novo Nordisk·Phase 2·NCT05725902·12 enrolled

Show 4 more trials

A Study of Etavopivat in Adults and Adolescents With Sickle Cell Disease (HIBISCUS)

Active, not recruiting·FForma Therapeutics, Inc.·Phase 3·NCT04624659·450 enrolled

A Study of Etavopivat in Patients With Thalassemia or Sickle Cell Disease

Completed·FForma Therapeutics, Inc.·Phase 2·NCT04987489·53 enrolled

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

Recruiting·Novo Nordisk·Phase 3·NCT06612268·408 enrolled

A Study to Evaluate the Pharmacokinetics and Safety of Etavopivat in Pediatric Patients With Sickle Cell Disease

Recruiting·FForma Therapeutics, Inc.·Phase 2·NCT06198712·50 enrolled

ART1 trial

A Research Study of the Effect of Food on Etavopivat in Healthy Participants

Completed·Novo Nordisk·Phase 1·NCT06433661·16 enrolled

Heart1 trial

A Study on the Effect of Etavopivat on Heart Rhythm in Healthy Participants

Completed·Novo Nordisk·Phase 1·NCT07023029·33 enrolled

Single Dose1 trial

A Research Study Looking at a Single Dose of Etavopivat in Healthy Chinese Participants

Completed·Novo Nordisk·Phase 1·NCT06581627·24 enrolled

Myelodysplastic Syndromes1 trial

A Study of Etavopivat for the Treatment of Anemia in Patients With Myelodysplastic Syndromes (MDS)

Terminated·FForma Therapeutics, Inc.·Phase 2·NCT05568225·17 enrolled

2 more indications

Drug1 trial

A Research Study of the Effect of Etavopivat on Other Drugs in Healthy Participants

Completed·Novo Nordisk·Phase 1·NCT06813924·37 enrolled

Liver Disease1 trial

A Research Study on Etavopivat in Participants With and Without Liver Disease

Completed·Novo Nordisk·Phase 1·NCT06336018·48 enrolled

Details

Drug Info

Related News